The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Kunihisa Nakai; Shin Mineishi; Masahiro Kami; Yoshinobu Konda; Ryuji Tanosaki; Yoichi Takaue

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Kunihisa Nakai, Shin Mineishi, Masahiro Kami, Yoshinobu Konda, Ryuji Tanosaki, Yoichi Takaue

Research output: Contribution to journal › Article › peer-review

Abstract

It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

Original language	English
Pages (from-to)	115-117
Number of pages	3
Journal	Haematologica
Volume	88
Issue number	1
Publication status	Published - 2003 Feb 1
Externally published	Yes

Keywords

Engraftment
GVHD
Mismatched reduced-intensity stem cell transplantation

ASJC Scopus subject areas

Hematology

Fingerprint Dive into the research topics of 'The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch'. Together they form a unique fingerprint.

Cite this

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch. / Nakai, Kunihisa; Mineishi, Shin; Kami, Masahiro; Konda, Yoshinobu; Tanosaki, Ryuji; Takaue, Yoichi.

In: Haematologica, Vol. 88, No. 1, 01.02.2003, p. 115-117.

Research output: Contribution to journal › Article › peer-review

@article{683a5a67c97e4698a5457a494fdecbcd,

title = "The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch",

abstract = "It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.",

keywords = "Engraftment, GVHD, Mismatched reduced-intensity stem cell transplantation",

author = "Kunihisa Nakai and Shin Mineishi and Masahiro Kami and Yoshinobu Konda and Ryuji Tanosaki and Yoichi Takaue",

year = "2003",

month = feb,

day = "1",

language = "English",

volume = "88",

pages = "115--117",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "1",

}

TY - JOUR

T1 - The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

AU - Nakai, Kunihisa

AU - Mineishi, Shin

AU - Kami, Masahiro

AU - Konda, Yoshinobu

AU - Tanosaki, Ryuji

AU - Takaue, Yoichi

PY - 2003/2/1

Y1 - 2003/2/1

N2 - It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

AB - It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

KW - Engraftment

KW - GVHD

KW - Mismatched reduced-intensity stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=0037311030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037311030&partnerID=8YFLogxK

M3 - Article

C2 - 12551837

AN - SCOPUS:0037311030

VL - 88

SP - 115

EP - 117

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Cite this